Cargando…
Hepatitis B vaccination and immunotherapies: an update
World Health Organization (WHO) estimates that 257 million people were living with chronic hepatitis B virus (HBV) infection. Highest HBV prevalence was found in the WHO Western Pacific Region (6.2%) and in the WHO African Region (6.1%). The HBV vaccine is the best protection against chronic HBV inf...
Autores principales: | Stasi, Cristina, Silvestri, Caterina, Voller, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Vaccine Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024731/ https://www.ncbi.nlm.nih.gov/pubmed/32095435 http://dx.doi.org/10.7774/cevr.2020.9.1.1 |
Ejemplares similares
-
Emerging Trends in Epidemiology of Hepatitis B Virus Infection
por: Stasi, Cristina, et al.
Publicado: (2017) -
Update on Hepatitis C Epidemiology: Unaware and Untreated Infected Population Could Be the Key to Elimination
por: Stasi, Cristina, et al.
Publicado: (2020) -
SARS-CoV-2 Vaccination and the Bridge between First and Fourth Dose: Where Are We?
por: Stasi, Cristina, et al.
Publicado: (2022) -
Treatment for COVID-19: An overview
por: Stasi, Cristina, et al.
Publicado: (2020) -
Attempt to calculate the prevalence and features of chronic hepatitis C infection in Tuscany using administrative data
por: Silvestri, Caterina, et al.
Publicado: (2016)